Measles: A disease that’s making a comeback
DOI:
https://doi.org/10.12775/JEHS.2022.12.09.032Keywords
measles virus, measles, vaccination against measles, measles epidemiology, measles symptomsAbstract
Introduction: Measles is a highly contagious viral disease that occurs around the world, featured by fever and the characteristic maculopapular rash, which can also be associated with cough, conjunctivitis or coryza. In recent years, there has been an alarming increase in the amount of measles cases in many countries around the world. The aim of this study is to review the literature and systematize knowledge about measles.
Brief description of the state of knowledge: The disease is caused by the measles virus, which is highly infectious, and its only reservoir is humans. The infection occurs via droplets, and the disease is a three-phase course. Unfortunately, measles is behind multiple complications, which may lead to death. In view of no specific antiviral therapies available for the treatment of measles, controlling the spread of the disease depends on prophylaxis, that is the use of widely available and effective vaccination against measles. Despite the presence of vaccines, there is still a substantial risk of further endemic outbreaks.
Conclusions: Nowadays, the elimination of measles is a major challenge due to increasing population density, ongoing wars, pandemics and other social and political factors. Hence, it remains paramount to make every effort to increase the quantity of people vaccinated against measles and to control its spread globally.
References
Hübschen JM, Gouandjika-Vasilache I, Dina J. Measles. Lancet. 2022 Feb 12;399(10325):678-690. doi: 10.1016/S0140-6736(21)02004-3. Epub 2022 Jan 28. PMID: 35093206.
Patel MK, Goodson JL, Alexander JP, Kretsinger K, Sodha SV, Steulet C, Gacic-Dobo M, Rota PA, McFarland J, Menning L, Mulders MN, Crowcroft NS. Progress toward regional measles elimination - worldwide, 2000-2019. Morb Mortal Wkly Rep [Internet]. 2020;69(45):1700-5. Available from: www.scopus.com
Keegan R, Dabbagh A, Strebel PM, Cochi SL. Comparing measles with previous eradication programs: enabling and constraining factors. J Infect Dis. 2011 Jul;204 Suppl 1:S54-61. doi: 10.1093/infdis/jir119. PMID: 21666211.
Moss WJ. Measles. Lancet. 2017 Dec 2;390(10111):2490-2502. doi: 10.1016/S0140-6736(17)31463-0. Epub 2017 Jun 30. PMID: 28673424.
Laksono BM, de Vries RD, Duprex WP, de Swart RL. Measles pathogenesis, immune suppression and animal models. Curr Opin Virol. 2020 Apr;41:31-37. doi: 10.1016/j.coviro.2020.03.002. Epub 2020 Apr 24. PMID: 32339942.
Chen HL, Tang RB. Measles re-emerges and recommendation of vaccination. J Chin Med Assoc. 2020 Jan;83(1):5-7. doi: 10.1097/JCMA.0000000000000210. PMID: 31569091.
“Measles.” https://www.who.int/news-room/fact-sheets/detail/measles (accessed Aug. 10, 2022).
“OdraSzczepienia.Info.”https://szczepienia.pzh.gov.pl/szczepionki/odra/?strona=3#jakie-sa-objawy-odry (accessed Aug. 09, 2022).
Leung AK, Hon KL, Leong KF, Sergi CM. Measles: a disease often forgotten but not gone. Hong Kong Med J. 2018 Oct;24(5):512-520. doi: 10.12809/hkmj187470. PMID: 30245481.
Griffin DE. Measles virus persistence and its consequences. Curr Opin Virol. 2020 Apr;41:46-51. doi: 10.1016/j.coviro.2020.03.003. Epub 2020 May 5. PMID: 32387998; PMCID: PMC7492426.
Charlier C, Dina J, Freymuth F, Vabret A, Lortholary O, Antona D, Lecuit M. Prolonged Maternal Shedding and Maternal-fetal Transmission of Measles Virus. Clin Infect Dis. 2021 May 4;72(9):1631-1634. doi: 10.1093/cid/ciaa915. PMID: 32614433.
Bansal J, Hameed A. Measles in pregnancy. BMJ Case Rep. 2019 May 9;12(5):e228781. doi: 10.1136/bcr-2018-228781. PMID: 31076492; PMCID: PMC6536234.
Xerri T, Darmanin N, Zammit MA, Fsadni C. Complications of measles: a case series. BMJ Case Rep. 2020 Feb 17;13(2):e232408. doi: 10.1136/bcr-2019-232408. PMID: 32066574; PMCID: PMC7206919.
Bohmwald K, Gálvez NMS, Ríos M, Kalergis AM. Neurologic Alterations Due to Respiratory Virus Infections. Front Cell Neurosci. 2018 Oct 26;12:386. doi: 10.3389/fncel.2018.00386. PMID: 30416428; PMCID: PMC6212673.
Watanabe S, Shirogane Y, Sato Y, Hashiguchi T, Yanagi Y. New Insights into Measles Virus Brain Infections. Trends Microbiol. 2019 Feb;27(2):164-175. doi: 10.1016/j.tim.2018.08.010. Epub 2018 Sep 13. PMID: 30220445.
Mathieu C, Bovier FT, Ferren M, Lieberman NAP, Predella C, Lalande A, Peddu V, Lin MJ, Addetia A, Patel A, Outlaw V, Corneo B, Dorrello NV, Briese T, Hardie D, Horvat B, Moscona A, Greninger AL, Porotto M. Molecular Features of the Measles Virus Viral Fusion Complex That Favor Infection and Spread in the Brain. mBio. 2021 Jun 29;12(3):e0079921. doi: 10.1128/mBio.00799-21. Epub 2021 Jun 1. PMID: 34061592; PMCID: PMC8263006.
Schoini P, Karampitsakos T, Avdikou M, Athanasopoulou A, Tsoukalas G, Tzouvelekis A. Measles pneumonitis. Adv Respir Med. 2019;87(1):63-67. doi: 10.5603/ARM.a2019.0010. Epub 2019 Mar 4. PMID: 30830960.
Memon SA, Afzal SS, Tukruna A, Khan AT, Tebha SS, Zaidi ZA. Trends and Treatment of Sub-Acute Sclerosing Panencephalitis: An Updated Review. Glob Pediatr Health. 2021 Dec 21;8:2333794X211065330. doi: 10.1177/2333794X211065330. PMID: 34988262; PMCID: PMC8721695.
Hao L, Ma C, Wannemuehler KA, Su Q, An Z, Cairns L, Quick L, Rodewald L, Liu Y, He H, Xu Q, Ma Y, Yu W, Zhang N, Li L, Wang N, Luo H, Wang H, Gregory CJ. Risk factors for measles in children aged 8 months-14 years in China after nationwide measles campaign: A multi-site case-control study, 2012-2013. Vaccine. 2016 Dec 12;34(51):6545-6552. doi: 10.1016/j.vaccine.2016.02.005. Epub 2016 Feb 11. PMID: 26876440; PMCID: PMC6293465.
Ma C, Hao L, Rodewald L, An Q, Wannemuehler KA, Su Q, An Z, Quick L, Liu Y, Yan R, Liu X, Zhang Y, Yu W, Zhang X, Wang H, Cairns L, Luo H, Gregory CJ. Risk factors for measles virus infection and susceptibility in persons aged 15 years and older in China: A multi-site case-control study, 2012-2013. Vaccine. 2020 Apr 3;38(16):3210-3217. doi: 10.1016/j.vaccine.2020.03.006. Epub 2020 Mar 12. PMID: 32173094.
A. Bailey and A. Sapra, “MMR Vaccine,” Cambridge Handbook of Psychology, Health and Medicine, Second Edition, pp. 781–783, Jun. 2022, doi: 10.1017/CBO9780511543579.201.
Papaevangelou V. Measles vaccination of special risk groups. Hum Vaccin Immunother. 2021 Dec 2;17(12):5384-5387. doi: 10.1080/21645515.2021.1997034. Epub 2021 Nov 17. PMID: 34788199; PMCID: PMC8903983.
Arora M, Lakshmi R. Vaccines - safety in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2021 Oct;76:23-40. doi: 10.1016/j.bpobgyn.2021.02.002. Epub 2021 Feb 19. PMID: 33773923; PMCID: PMC7992376.
“UNICEF i WHO ostrzegają przed wybuchem epidemii chorób zakaźnych u dzieci - Szczepienia.Info.” https://szczepienia.pzh.gov.pl/unicef-i-who-ostrzegaja-przed-wybuchem-epidemii-chorob-zakaznych-u-dzieci/ (accessed Aug. 08, 2022).
“Global Measles Outbreaks.” https://www.cdc.gov/globalhealth/measles/data/global-measles-outbreaks.html (accessed Aug. 06, 2022).
“Jaka jest liczba uchyleń dotyczących szczepień obowiązkowych? - Szczepienia.Info.” https://szczepienia.pzh.gov.pl/faq/jaka-jest-liczba-uchylen-szczepien-obowiazkowych/ (accessed Aug. 10, 2022).
“Jaki jest stan zaszczepienia przeciw odrze w Polsce? - Szczepienia.Info.” https://szczepienia.pzh.gov.pl/faq/jaki-jest-stan-zaszczepienia-przeciw-odrze-w-polsce/#jakie-argumenty-przemawiaja-za-uzupelnieniem-drugiej-dawki-szczepionki-mmr-przeciw-odrze,-swince-i-rozyczce (accessed Aug. 07, 2022).
“Odra - Szczepienia.Info.” https://szczepienia.pzh.gov.pl/szczepionki/odra/?strona=4#jak-wiele-zachorowan-na-odre-wystepowalo-w-polsce-przed-i-po-wprowadzeniu-szczepien- (accessed Aug. 07, 2022).
“Jakie argumenty przemawiają za uzupełnieniem drugiej dawki szczepionki MMR przeciw odrze, śwince i różyczce? - Szczepienia.Info.” https://szczepienia.pzh.gov.pl/faq/jakie-argumenty-przemawiaja-za-uzupelnieniem-drugiej-dawki-szczepionki-mmr-przeciw-odrze-swince-i-rozyczce/?wersja=dla-pacjentow (accessed Aug. 07, 2022).
“Measles cases are spiking globally | UNICEF.” https://www.unicef.org/stories/measles-cases-spiking-globally (accessed Aug. 06, 2022).
“Communicable disease threats report, 10 - 16 July, week 28.” https://www.ecdc.europa.eu/en/publications-data/communicable-disease-threats-report-10-16-july-week-28 (accessed Aug. 06, 2022).
“Early warning, alert and response to acute public health events in refugee-hosting countries Ukraine crisis”.
“Co wiemy na temat stanu zaszczepienia dzieci w Ukrainie przed chorobami zakaźnymi przed którymi chronią szczepienia? - Szczepienia.Info.” https://szczepienia.pzh.gov.pl/faq/co-wiemy-na-temat-stanu-zaszczepienia-dzieci-w-ukrainie-przed-chorobami-zakaznymi-przed-ktorymi-chronia-szczepienia/?wersja=dla-pacjentow (accessed Aug. 07, 2022).
Summary and Conclusions: Measles Elimination Meeting, 16–17 March 2000, The Journal of Infectious Diseases, Volume 189, Issue Supplement_1, May 2004, Pages S43–S47, https://doi.org/10.1086/377696
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Małgorzata Bojarska, Natalia Domańska, Anna Brzyska, Julia Bogucka, Natalia Wilczek, Halina Piecewicz-Szczęsna
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 1459
Number of citations: 0